PITTSBURGH & HOUSTON – (COMMERCIAL THREAD) – AccessDX Holdings, a global provider of advanced laboratory diagnostic solutions, has acquired 2bPrecise â¢ from Allscripts Healthcare Solutions. A recognized leader and innovator in healthcare IT, 2bPrecise enables organizations to scale up their precision medicine strategies by providing point-of-care information so providers can identify patients at risk for hereditary diseases, make accurate diagnoses faster and initiate optimal therapies faster.
2bPrecise will join the AccessDX portfolio of industry-leading diagnostics, software and services, including the MedTek21 software platform that facilitates clinical decision support based on diagnosis, compliance and program analysis for thousands of organizations care, patient groups and providers. The combined strengths of AccessDX and 2bPrecise ensure that meaningful information will be accessible in the clinical workflow of any EHR, while helping organizations streamline virtually every aspect of establishing and supporting precision medicine programs. .
âWe are delighted to welcome the 2bPrecise team and platform as we implement our combined vision of democratizing the use, interpretation and delivery of advanced diagnostic solutions at the point of care. Said Joe Spinelli, senior vice president of product and strategy for AccessDX. âTogether, our global organization will be able to accelerate the pace of innovation and better meet the needs of healthcare organizations as they continue to expand their adoption of actionable precision medicine solutions. ”
The use of genetic and genomic data is accelerating in almost all clinical specialties, perhaps more particularly in behavioral health / psychiatry, neonatology and pediatrics, oncology and cardiology. Providers can arrive at accurate diagnoses faster and initiate effective treatments earlier when genetic and genomic information is available and usable. Providers, payers, and clinical organizations agree that the ability to seamlessly access information in their clinical workflow is key to the success of precision medicine.
âAccessDX is a true leader in the management of genomic information. Our collective capabilities will serve as a multiple force for the practical use of precision medicine, âsaid Assaf Halevy, Founder and CEO of 2bPrecise. “With a unified mission to drive dimensional change in healthcare, the combined talents and energy of 2bPrecise and AccessDX will accelerate the realization of our vision of intelligent, personalized care for the benefit of healthcare organizations and patients. that they serve. ”
About the AccessDX lab
The AccessDX Lab is a CLIA Certified, CAP and NYCQ accredited diagnostic laboratory dedicated to providing clinical information that improves patient outcomes. AccessDX diagnostic solutions include COVID-19 testing, pharmacogenomic testing (PGX), cancer genomic testing (CGX), respiratory pathogen panels and a wide range of other clinical laboratory services. AccessDX diagnostic and software solutions are currently trusted by thousands of clinical providers in healthcare systems nationwide. For more information, please visit www.AccessDXlab.com.
MedTek21 is a real-time population health and drug risk management platform that provides personalized drug-to-gene monitoring to each patient. The company’s software platform works with existing medical record systems to continuously monitor, proactively identify, and help address potential drug risks. MedTek21’s mobile drug risk alerts, drug search tools, actionable reports and clinical support staff empower patients and their care providers to make better decisions in real time. MedTek21 is used to positively impact outcomes and reduce costs of care for tens of thousands of patients in general, acute and chronic populations. For more information on MedTek21, please visit www.MedTek21.com.
The 2bPrecise platform consumes genetic / genomic data from molecular laboratories and clinical information from EHRs, synthesizing them into a clinical-genomic ontology. It brings the resulting precision medicine information into a physician’s EHR workflow for immediate and timely use. With discrete test results consolidated into an invaluable data set, provider organizations are equipped to manage efficient workflows for genomic workflows and decision-making, extract population analyzes, design intervention programs clinical trial, form cohorts for trial recruitment, enable participation in research studies and more. www.2bPreciseHealth.com.